L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as...
London-based biotech Engitix has raised US$25m in a Series A extension, with billionaire hedge fund founder Mike Platt backing the company for the second time. The...
TECregen has raised CHF 10m [£9,300,000] in seed financing to develop therapies aimed at rejuvenating the thymus, a gland that produces immune cells. The Basel-based biotechnology...
Corsera Health has raised US$80m in Series A funding to develop preventive RNAi medicines and AI tools to predict and prevent cardiovascular disease. The Boston-based company...
Captify won AARP’s AgeTech pitch at CES, taking US$10,000 for captioning glasses that show real-time subtitles for people with hearing loss. San Francisco-based Captify beat four...
The longer someone has type 2 diabetes, the higher their cardiovascular disease risk, and changes in red blood cells may help explain it, new research suggests....
Routine vaccines for adults may reduce dementia risk, a review of more than 100 million people suggests. The research found both flu and shingles vaccines were...
